Literature DB >> 2412140

Positive inotropic effect of Bay K 8644: cAMP-independence and lack of inhibitory effect of adenosine.

M Böhm, H Burmann, W Meyer, M Nose, W Schmitz, H Scholz.   

Abstract

The aim of the present study was to characterize the positive inotropic effect of the Ca2+ channel activator Bay K 8644. In isolated guinea-pig papillary muscles we investigated whether adenosine and the R site adenosine receptor agonist (-)-N6-phenylisopropyladenosine (PIA) were able to antagonize the positive inotropic effect of Bay K 8644. The effect of Bay K 8644 and adenosine or PIA on myocardial cAMP content was also measured. The influence of adenosine and PIA on the positive inotropic effect of the beta-adrenoceptor agonist isoprenaline and of the phosphodiesterase inhibitor amrinone was studied for comparison. Adenosine and PIA antagonized the positive inotropic effects of isoprenaline and amrinone in a concentration-dependent manner. In contrast, adenosine or PIA did not affect the positive inotropic effect of Bay K 8644. The positive inotropic effect of Bay K 8644 was not accompanied by a change in the cAMP content of the papillary muscles. Additionally applied adenosine or PIA also failed to affect the cAMP content. It is concluded that an increased myocardial cAMP content is not involved in the positive inotropic effect of Bay K 8644. Moreover, the results support the view that adenosine and PIA only antagonize the positive inotropic effects of drugs known to increase myocardial cAMP content and that an increased myocardial cAMP content is a prerequisite for the manifestation of a negative inotropic effect of the nucleosides in ventricular cardiac muscle.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412140     DOI: 10.1007/bf00496380

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  16 in total

1.  Adenosine as inhibitor of myocardial effects of catecholamines.

Authors:  J Schrader; G Baumann; E Gerlach
Journal:  Pflugers Arch       Date:  1977-11-25       Impact factor: 3.657

2.  Interaction between adenosine and catecholamines on cyclic AMP accumulation in guinea pig ventricular myocardium.

Authors:  M Huang; G I Drummond
Journal:  Biochem Pharmacol       Date:  1978-01-15       Impact factor: 5.858

3.  Involvement of cyclic AMP in the direct inotropic action of amrinone. Biochemical and functional evidence.

Authors:  P Honerjäger; M Schäfer-Korting; M Reiter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

4.  Subclasses of external adenosine receptors.

Authors:  C Londos; D M Cooper; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

5.  Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect.

Authors:  M Böhm; R Brückner; I Hackbarth; B Haubitz; R Linhart; W Meyer; B Schmidt; W Schmitz; H Scholz
Journal:  J Pharmacol Exp Ther       Date:  1984-08       Impact factor: 4.030

6.  Mechanism of adenosine inhibition of catecholamine-induced responses in heart.

Authors:  J G Dobson
Journal:  Circ Res       Date:  1983-02       Impact factor: 17.367

7.  Inhibitory action of adenosine on histamine- and dopamine-stimulated cardiac contractility and adenylate cyclase in guinea pigs.

Authors:  G Baumann; J Schrader; E Gerlach
Journal:  Circ Res       Date:  1981-02       Impact factor: 17.367

8.  Modification by islet-activating protein of receptor-mediated regulation of cyclic AMP accumulation in isolated rat heart cells.

Authors:  O Hazeki; M Ui
Journal:  J Biol Chem       Date:  1981-03-25       Impact factor: 5.157

9.  Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle.

Authors:  M Endoh; S Yamashita; N Taira
Journal:  J Pharmacol Exp Ther       Date:  1982-06       Impact factor: 4.030

10.  Modification by islet-activating protein of direct and indirect inhibitory actions of adenosine on rat atrial contraction in relation to cyclic nucleotide metabolism.

Authors:  M Endoh; M Maruyama; N Taira
Journal:  J Cardiovasc Pharmacol       Date:  1983 Jan-Feb       Impact factor: 3.105

View more
  8 in total

1.  Effects of calcium channel agonism by Bay-K-8644 on ventricular fibrillation threshold of isolated heart.

Authors:  M G Worthington; L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1992-12       Impact factor: 3.727

2.  Involvement of purine compounds in the inotropic action of milrinone.

Authors:  P Dorigo; R M Gaion; I Maragno
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

3.  [Cardiac effects of adenosine. Mechanism of action, pathophysiologic and clinical significance].

Authors:  M Böhm
Journal:  Klin Wochenschr       Date:  1987-06-01

4.  Positive chronotropic effect of Bay K 8644: participation of endogenous norepinephrine.

Authors:  M C de Hurtado; O A Gende; H E Cingolani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

5.  Evidence for adenosine receptor-mediated isoprenaline-antagonistic effects of the adenosine analogs PIA and NECA on force of contraction in guinea-pig atrial and ventricular cardiac preparations.

Authors:  M Böhm; R Brückner; W Meyer; M Nose; W Schmitz; H Scholz; J Starbatty
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

6.  Comparison between the cardiac effects induced by muzolimine and furosemide in guinea-pig atria.

Authors:  P Dorigo; R M Gaion; M Bergamin; A Giacometti; E Valentini; I Maragno
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

7.  Modulation of calcium channel currents in guinea-pig single ventricular heart cells by the dihydropyridine Bay K 8644.

Authors:  F Markwardt; B Nilius
Journal:  J Physiol       Date:  1988-05       Impact factor: 5.182

8.  Adenosine inhibits the positive inotropic effect of 3-isobutyl-1-methylxanthine in papillary muscles without effect on cyclic AMP or cyclic GMP.

Authors:  M Böhm; R Brückner; J Neumann; M Nose; W Schmitz; H Scholz
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.